Home | Welcome to Contract Pharma   
Last Updated Sunday, April 19 2015

Print RSS Feed

Search Results for 'Financial Report: Alkermes'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Published April 13, 2015
Diversifies development risk with second, complementary acute pain product Read More »
Published March 9, 2015
Streamlines manufacturing ops into Athlone and Wilmington facilities Read More »
Published October 31, 2014
Revenues up 14% in the quarter Read More »
Published April 30, 2014
Manufacturing and royalty revenues down 24% in the quarter Read More »
By Gil Roth
Published January 6, 2014
Expects to begin trials of MS prodrug in mid-2014 Read More »
Published July 25, 2013
Key commercial products up 22% in the quarter Read More »
Alkermes
By Fidelma Callanan, Sr. Director Marketing and Commercial Development
Four decades delivering contract pharma solutions for our Partners Alkermes Contract Pharma Services provid… Read More »
Newsmakers: James L. Botkin
By Gil Y. Roth, Contract Pharma
Published May 30, 2012
Alkermes’ James L. Botkin Read More »
By Thomas J. Edkins, PhD, Principal
MEGGLE USA, Inc.
By Ken Seufert
MEGGLE Excipients & Technology is a global leader in the manufacture of lactose for the pharmaceutical industry. Supporting supply chain security with manufacturing facilities in Europe and North America, MEGGLE offers a broad product portfolio o… Read More »


Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On